Skip to content

EBIT at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$33M+140%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-$6.12M+76.7%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Glaukos logo
GlaukosGKOS

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.15B+17.1%

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Calculated from Warby Parker’s reported figures.

Plus components not separately reported this period.

The official record: Warby Parker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's EBIT?
Warby Parker (WRBY) reported EBIT of $1.67M in Q1 2026.
How has Warby Parker's EBIT changed year-over-year?
Warby Parker's EBIT decreased by 32.5% year-over-year, from $2.47M to $1.67M.
What is the long-term trend for Warby Parker's EBIT?
Over 4 years (2021 to 2025), Warby Parker's EBIT has grown at a -56.1% compound annual growth rate (CAGR), from -$143.66M to -$5.34M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.